12/19/2024
6:38 AM | Ampliphi Biosciences (Filer)
Armata Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2024
3:15 PM | Ampliphi Biosciences (Filer)
Armata Pharmaceuticals, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/12/2024
6:07 AM | Ampliphi Biosciences (Filer)
Armata Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/03/2024
3:15 PM | Ampliphi Biosciences (Issuer)
Armata Pharmaceuticals, Inc. (Issuer)
House David Duane (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
3:15 PM | Ampliphi Biosciences (Filer)
Armata Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/26/2024
3:33 PM | Ampliphi Biosciences (Filer)
Armata Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/26/2024
6:50 AM | Ampliphi Biosciences (Filer)
Armata Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
08/19/2024
3:15 PM | Ampliphi Biosciences (Issuer)
Armata Pharmaceuticals, Inc. (Issuer)
House David Duane (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/15/2024
4:00 PM | Ampliphi Biosciences (Filer)
Armata Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/13/2024
3:20 PM | Ampliphi Biosciences (Filer)
Armata Pharmaceuticals, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/13/2024
3:15 PM | Ampliphi Biosciences (Filer)
Armata Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/28/2024
5:12 PM | Ampliphi Biosciences (Issuer)
Armata Pharmaceuticals, Inc. (Issuer)
Kyme Pierre (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/07/2024
3:25 PM | Ampliphi Biosciences (Filer)
Armata Pharmaceuticals, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
03/22/2024
7:00 AM | Ampliphi Biosciences (Filer)
Armata Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/21/2024
3:20 PM | Ampliphi Biosciences (Filer)
Armata Pharmaceuticals, Inc. (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/21/2024
3:15 PM | Ampliphi Biosciences (Filer)
Armata Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/18/2024
7:00 PM | Ampliphi Biosciences (Issuer)
Armata Pharmaceuticals, Inc. (Issuer)
Birx Deborah (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2024
7:00 PM | Ampliphi Biosciences (Issuer)
Armata Pharmaceuticals, Inc. (Issuer)
Odysseas Kostas D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2024
7:01 PM | Ampliphi Biosciences (Issuer)
Armata Pharmaceuticals, Inc. (Issuer)
Haimovitz Jules (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2024
7:02 PM | Ampliphi Biosciences (Issuer)
Armata Pharmaceuticals, Inc. (Issuer)
Schlesinger Sarah J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2024
7:02 PM | Ampliphi Biosciences (Issuer)
Armata Pharmaceuticals, Inc. (Issuer)
Rychlik Richard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2024
7:03 PM | Ampliphi Biosciences (Issuer)
Armata Pharmaceuticals, Inc. (Issuer)
Peterson Todd C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2024
7:03 PM | Ampliphi Biosciences (Issuer)
Armata Pharmaceuticals, Inc. (Issuer)
Kramer Robin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2024
7:05 PM | Ampliphi Biosciences (Issuer)
Armata Pharmaceuticals, Inc. (Issuer)
PATTI JOSEPH M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
4:35 PM | Ampliphi Biosciences (Subject)
Armata Pharmaceuticals, Inc. (Subject)
Innoviva, Inc. (Filed by)
| Form SC 13D/A | |
01/23/2024
3:17 PM | Ampliphi Biosciences (Filer)
Armata Pharmaceuticals, Inc. (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
12/26/2023
8:53 PM | Ampliphi Biosciences (Issuer)
Armata Pharmaceuticals, Inc. (Issuer)
Odysseas Kostas D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2023
8:53 PM | Ampliphi Biosciences (Issuer)
Armata Pharmaceuticals, Inc. (Issuer)
Birx Deborah (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2023
8:53 PM | Ampliphi Biosciences (Issuer)
Armata Pharmaceuticals, Inc. (Issuer)
Haimovitz Jules (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2023
8:54 PM | Ampliphi Biosciences (Issuer)
Armata Pharmaceuticals, Inc. (Issuer)
Rychlik Richard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2023
8:54 PM | Ampliphi Biosciences (Issuer)
Armata Pharmaceuticals, Inc. (Issuer)
PATTI JOSEPH M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2023
8:54 PM | Ampliphi Biosciences (Issuer)
Armata Pharmaceuticals, Inc. (Issuer)
Kramer Robin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2023
8:55 PM | Ampliphi Biosciences (Issuer)
Armata Pharmaceuticals, Inc. (Issuer)
Peterson Todd C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2023
8:55 PM | Ampliphi Biosciences (Issuer)
Armata Pharmaceuticals, Inc. (Issuer)
Schlesinger Sarah J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Free APHB Stock Alerts